Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Thoracic 6Other hematologic neoplasm 4Gastrointestinal 4Myeloid 3Lymphoid 3Gynecologic 3Dermatologic 3CNS 3Sarcoma 2Head & Neck 2Tumor-Agnostic 1Plasma cell 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sodium Chloride × Genitourinary × Clear all
NCT03824808 2023-10-25

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

University of Missouri-Columbia

Phase 4 Terminated
21 enrolled 12 charts
Genitourinary

Kidney Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡